ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Zymergen Inc

Zymergen Inc (ZY)

2.43
0.00
(0.00%)
마감 21 9월 5:00AM
0.00
0.00
(0.00%)
시간외 거래: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
2.43
매수가
2.30
매도가
2.31
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
2.43
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

ZY 최신 뉴스

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks...

Ginkgo to Acquire Zymergen

Ginkgo to Acquire Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., July 25, 2022 Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology...

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to...

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular...

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...

Zymergen Reports Preliminary First Quarter 2022 Financial Results

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended...

Zymergen to Participate in the BofA Securities 2022 Healthcare Conference

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022...

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after...

Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BNZIBanzai International Inc
US$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
US$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
US$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
US$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
US$ 1.34
(-82.89%)
26.41M
CRBPCorbus Pharmaceuticals Holdings Inc
US$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
US$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
US$ 0.0855
(-42.27%)
15.04M
SKYESkye Bioscience Inc
US$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
US$ 116.00
(-1.59%)
378.15M
AAPLApple Inc
US$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
US$ 21.84
(3.31%)
261.64M
VERBVerb Technology Company Inc
US$ 0.0742
(33.45%)
178.64M

ZY Discussion

게시물 보기
janice shell janice shell 5 일 전
I know. I just posted to the last person who'd had something to say about this company.
👍️0
Triple nickle Triple nickle 5 일 전
My post date was 2022
👍️0
janice shell janice shell 7 일 전
What date? The complaint was filed in federal court today.
👍️0
Triple nickle Triple nickle 7 일 전
Check that date
👍️0
janice shell janice shell 1 주 전
fwiw:

SEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales Prospects

https://www.sec.gov/newsroom/press-releases/2024-129

The Complaint:

https://www.sec.gov/files/litigation/admin/2024/33-11303.pdf
👍️0
Triple nickle Triple nickle 2 년 전
About time here
👍️0
Wake Setter Wake Setter 3 년 전
Still a great opportunity here. Once all the law firms quit spamming the news wires for ZY and the company gives new guidance we could see some steps up.

$8.40 was a gift from God
👍️0
$treet $inatra $treet $inatra 3 년 전
great pop and even greater upside for the longer term holders, congrats!
👍️0
JstnDFW JstnDFW 3 년 전
Such a good buy this morning! Congrats to those that got in on early trading today.
👍️0
$treet $inatra $treet $inatra 3 년 전
yep, looking great!! back to $35+
👍️0
Roadtojourney Roadtojourney 3 년 전
Kathy wood bought 2.5 milly as well??
👍️0
JstnDFW JstnDFW 3 년 전
Back to 20-30 dollar range here!
👍️0
Wake Setter Wake Setter 3 년 전
ZY good chance for recovery here, great entry for synthetic bio industry. Dramatically oversold - over reaction.
👍️0
ciciagt ciciagt 3 년 전
Yes, news is bad. Softbank and others can’t be pleased. Issues with Hyaline, management shake up, and maybe ‘meager’ revenues in 2022. Pitiful.
👍️0
conix conix 3 년 전
No revenues and no CEO.
👍️0
ciciagt ciciagt 3 년 전
Yikes….
👍️0
Lowjack Lowjack 3 년 전
Did you at least get a chance to bend over first?

Holy CF!
👍️0
ciciagt ciciagt 3 년 전
I own Zymergen and watching a SPAC deal…SRNG and Gingko Bioworks.
https://www.forbes.com/sites/johncumbers/2020/06/25/if-biology-can-build-it-they-will-come-ginkgo-bioworks-is-laying-the-foundation-for-the-4-trillion-bioeconomy/?sh=1ca8193841e0
👍️0
janeyH janeyH 3 년 전
this is in my biosynthetic basket
👍️0
janeyH janeyH 3 년 전
'sup rt?
👍️0
rtrstock rtrstock 3 년 전
I've decided to start focusing on trading Initial Offerings again, it seemed percentage gainwise, to be strategical. So this is my next play.
👍️0

최근 히스토리

Delayed Upgrade Clock